A Rationally Designed Fully Human EGFRvIII:CD3-targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-Derived Intracerebral Malignant Glioma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0126
Full Text
Open PDFAbstract
Available in full text
Date
April 27, 2018
Authors
Publisher
American Association for Cancer Research (AACR)